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It is intuitive to think that sarcopenia should be associated with declines in physical function though recent evidence questions
this assertion. This study investigated the relationship between absolute and relative sarcopenia, with physical performance in
202 nonobese (mean BMI = 26.6kg/ht 2) community-dwelling older (mean age = 73.8 ± 5.9 years) adults. While absolute
sarcopenia (appendicular skeletal mass (ASM)/ht2) was either not associated, or weakly associated with physical performance,
relative sarcopenia (ASM/kg) demonstrated moderate (r = 0.31 to r = 0.51, P<0.01) relationships with performance outcomes
in both males and females. Knee extension strength (r = 0.27) and leg extension power (r = 0.41) were both related to absolute
sarcopenia (P<0.001) in females and not in males. Strength and power were associated with relative sarcopenia in both sexes
(from r = 0.47 to r = 0.67, P<0.001). The ratio of lean mass to total body mass, that is, relative sarcopenia, is an important
consideration relative to physical function in older adults even in the absence of obesity. Stratifying these individuals into equal
tertiles of total body fat revealed a trend of diminished regression coeﬃcients across each incrementally higher fat grouping for
performance measures, providing further evidence that total body fat modulates the relationship between sarcopenia and physical
function.
1.Introduction
It seems intuitive that muscle structure (lean) and function
(strength and power) are intricately linked to an older
individual’s level of physical function. Moreover, sarcopenia
or the age-associated loss of lean tissue, along with increased
whole-body and regional fat deposits, is a normal manifes-
tation of old age [1]. There is substantial debate, however, as
to whether sarcopenia can explain the age-diminished levels
of physical function in older individuals. A recent review
of the literature [1] highlights trends demonstrating that
high whole-body fat mass (obesity) is more inﬂuential than
low whole-body lean mass with respect to mobility and
functional decline. The current consensus statement from
the European Working Group on Sarcopenia in Older People
[2], not speciﬁcally highlighting obesity per se, also rein-
forces the notion that lean body mass alone is not adequate
to identify functional decline. Further, because absolute
sarcopenia, deﬁned as the ratio of appendicular skeletal mass
(ASM)toanindividual’sheightsquared(ASM/ht2),doesnot
demonstrate strong associations with physical function [3],
it follows that lean body mass only weakly explains the lower
levels of physical functioning in older adults.
While this uncoupling of lean body mass and physical
functioning may not be surprising in obese individuals,
it remains counterintuitive in those older adults who are
not obese. However, decreased activity and illness, which
commonly occur even in nonobese older adults, may result
in substantial loss of lean tissue mass while body fat remains
relatively constant or perhaps increased. It is likely, therefore,
thatthetraditionalBMIderiveddeﬁnitionofobesity(BMI ≥
30kg/m2) does not accurately identify abnormal body com-
position in older adults, who in particular are experiencing
a dual loss of lean tissue and an increase in adiposity,
even when their BMI falls below the obese level. Therefore,
the purpose of this paper is to determine in nonobese
older adults whether total body adiposity modulates the
relationship between sarcopenia and physical function.2 Current Gerontology and Geriatrics Research
2. Methods
2.1. Subjects. Participants eligible for this study were
recruited from an ongoing study via a large database of the
Utah Health Research Network from July 2007 to June 2009.
The recruitment strategy for the ongoing study utilized an
opt-out mailing system that required potential subjects not
interested in participating to call the study coordinator to
opt-out within 5 business days of receiving the recruitment
letter.Subjectswhodidnotoptoutwerecontactedviaphone
by a research assistant 10 days after receiving the letter.
Subjects were briefed about the study, their eligibility was
conﬁrmed, and they were verbally consented to participate.
Those interested in participating in the study were scheduled
foradualX-rayabsorptiometry (DXA)scanandthephysical
function tests on two separate days. A research assistant met
subjects at the ﬁrst of these two visits and administered
the written informed consent for study participation. The
inclusion criteria were age greater than 64 years, male or
female, total weight < 300 pounds, height < 6 5   (maximum
table weight and height for DXA), and a willingness to come
to the clinic for DXA and for physical function testing.
Subjects were excluded from participation if they had tests
with radiographic contrast material in the past 72 hours, had
participated in nuclearmedicine studies in the past 3days, or
were unable to independently ambulate.
2.2. Procedures. Participants underwent whole-body DXA to
provide estimates of lean and fat tissue mass (DXA, Hologic
QDR QDR-4500A; Waltham, MA) using the standardized
procedures of the manufacturer (software version 12.6.6:7).
Parameters for analysis were followed as identiﬁed in the
user’s guide (QDR Series User’s Guide, March 2000). A
quality control system has been established to optimize the
accuracy of the data obtained from the DXA. Calibration
of the DXA is conﬁrmed weekly through spine phantom
scans. Algorithms are in place to detect drift and suboptimal
performance of the machine, and no long-term bias was
evident in the phantom data. DXA scans were performed
by a single radiographer. Appendicular skeletal muscle mass
(ASM) was calculated from the sum of lean tissue mass for
the arms and legs [4], and total fat mass was calculated by
the sum of fat in the arms, legs, and trunk.
2.3. Physical Function Tests. Three physical performance
tests were used to quantify physical function in this group.
They included the six-minute walk (6MW) test, the 9-item
Physical Performance Test (PPT), and 4-meter gait speed.
The 6MW test is a measure of physical function and
walking endurance. The participants walked back and forth
in a hallway around, two which that were placed 25 meters
apart. The participants were instructed that the goal of the
assessment was to walk as far as possible in six minutes.
The 6MW test is a reliable performance-based measure of
physical function in older adult populations that is related to
overalllocomotorability[5,6].Six-minutewalkdistancewas
recorded as the total distance walked in meters and used for
analysis.
The modiﬁed 9-item PPT was used as a composite
assessment of physical function. This test is designed to
mimic activities of daily living and includes tests of standing
balance, moving from sit to stand, light lifting, putting on
and removing a jacket, walking, and stair climbing. The 9-
itemPPThasbeenshowntocorrelatewellwithdisabilityand
frailty[7].EachitemofthePPTisscoredfrom0to4,withthe
higher score indicating better performance. Total PPT score
out of 36 possible was used for analysis.
The four-meter gait speed test was performed over a 10-
meter walking course. Participants were instructed to walk at
theirpreferredwalkingpaceandtocontinuewalkingoverthe
entire 10-meter course. Timing took place over the middle
four meters of the walking course. Gait speed is a reliable
measurement that reﬂects health and functional status in
older adults [8]. Gait speed was measured in meters per
second.
2.4. Strength and Power Tests. Knee extension muscle
strength (strength) and leg extension muscle power were
quantiﬁed with a maximal isometric voluntary knee exten-
sion contraction test. Leg extension muscle power (power)
was quantiﬁed by a test of concentric leg extension power.
Isometric strength of the quadriceps femoris muscles
of each lower extremity was evaluated at 60◦ of knee
ﬂexiononadynamometer(Kin-Com500H,ChattecxCorp.;
Harrison, TN). Following three practice trials, participants
were tested three times with a two-minute rest between trials
to avoid muscle fatigue. The strength measures, which were
corrected for the inﬂuence of gravity, have demonstrated
highreliability(ICC =0.99)[9].Theaveragemaximumforce
value in newtons, normalized to BMI was used for analysis.
Leg extension power in each lower extremity was evalu-
ated using the leg extension (Nottingham) Power Rig. Par-
ticipants were positioned such that the hips were supported
in a seat, which was adjusted to allow for 90 degrees of
knee ﬂexion in the starting position and ∼5 degrees short
of full knee extension in the ﬁnishing position. Following 4-
5 practice trials, the participant performed 5 leg extension
maximal eﬀorts. The leg extension power rig is a feasible
means of assessing muscle power across the lifespan [10].
The average maximal eﬀort leg extension power in watts,
normalized to BMI was used for analysis.
2.5. Statistical Analysis. Data management and statistical
analyses were performed with PASW Statistics 18.0 (SPSS,
Chicago, IL). Descriptive data were calculated for demo-
graphic variables and dependent measures and are presented
as means ± SD. To determine the relationships between
the two separate sarcopenia indices, Spearman’s rank cor-
relations were calculated between both absolute and relative
sarcopenia and PPT, 6MW, gait speed, strength, and power
test scores. The Spearman’s rank correlation coeﬃcient is
a nonparametric test of association between two variables
[11]. This test was used instead of the Pearson’s product
moment correlation because of the nonnormality of distri-
bution of sarcopenia indices and dependent measures. To
determine how the relationship between absolute sarcopeniaCurrent Gerontology and Geriatrics Research 3
Table 1: Characteristics of the 202 participants (males n = 102, females n = 100).
Variable Males Females
mean (SD) mean (SD)
Age (years) 73.6 (5.8) 74.0 (6.1)
Body mass index (kg∗ m2) 26.6 (3.8) 26.6 (4.5)
Total fat (kg) 21.8 (7.8) 26.2 (8.9)
Total lean (kg) 53.2 (7.5) 36.4 (6.0)
Physical performance test (36 possible) 31.8 (4.4) 30.3 (4.7)
Knee extension strength (N) 384.5 (101.4) 247.0 (78.2)
6-minute walk (meters) 512.0 (109.5) 445.7 (106.6)
Self-selected gait speed (m/s)∗ 1.52 (0.26) 1.36 (0.29)
∗gait speed calculated by 4 meter gait speed test.
and the dependent measures was aﬀected by total body
fat, subjects were stratiﬁed, based on total body fat into
equaltertiles,andregressioncoeﬃcientswerethencalculated
separately in each tertile. The alpha level was set at <0.05.
3. Results
The subjects included 202 (100 females and 102 males)
nonobesecommunity-dwellingolderadultvolunteers.Char-
acteristics of the subjects are summarized in Table 1.
The prevalence of absolute sarcopenia in this group,
based on the criteria of Baumgartner et al. [12], was
deﬁned as ASM/ht2 < 7.26 for males and <5.45 for females.
Prevalenceofabsolutesarcopeniawas29.4%inthemalesand
28.0% in the females, with a range of 4.9–10.2 for males and
4.5–8.8 for females. The prevalence of relative sarcopenia,
based on criteria established by Estrada et al. [3], which was
deﬁned as ASM/kg total body mass < 0.29 for males and
<0.22 for females, was 42.2% in the males and 34.0% in the
females, with a range of 0.23–0.40 for males and 0.18–0.33 in
the females.
Absolute sarcopenia (ASM/ht2) was not signiﬁcantly
associated with the PPT, 6MW, or gait speed in males.
Absolute sarcopenia was weakly related to 6MW (r = 0.16,
P = 0.02) and gait speed (r = 0.14, P = 0.05) in females.
Relative sarcopenia (ASM/kg) was moderately associated
with the PPT (r = 0.43, P<0.001), 6MW (r = 0.48, P<
0.001), and gait speed (r = 0.31, P<0.01) in males, and
with the PPT (r = 0.39, P<. 001), 6MW (r = 0.51, P<
0.001), and gait speed (r = 0.41, P<0.001) in females. Knee
extension strength and leg extension power were also not
related to absolute sarcopenia in males but were related to
absolute sarcopenia in females (r = 0.27, r = 0.41, resp., P<
0.001). Knee extension strength and leg extension power
demonstrated signiﬁcant relationships with relative sarcope-
nia in both sexes (r = 0.67, r = 0.66 in females; r = 0.47, r =
0.48 in males P<0.001) (Table 2).
To examine how the relationship between absolute
sarcopenia and the dependent measures of PPT, 6MW, gait
speed, strength, and power were aﬀected by total body
fat, the subjects were stratiﬁed, by total body fat, into
equal tertiles (Figure 1). This analysis revealed diminished
regression coeﬃcients across each incrementally higher fat
grouping for the physical performance variables. In the low-
fat group, the relationships between absolute sarcopenia and
PPT (r = 0.44, P ≤ 0.001), and absolute sarcopenia and
6MW(r = 0.42, P<0.001), and absolute sarcopenia and
gait speed (r = 0.60, P<0.001) were higher than those in
the medium fat (PPT r = 0.23, P = 0.07, 6MW r = 0.40,
P = 0.001, gait speed r = 0.27, P = 0.03), or high fat group
(PPT r =− 0.20 P = 0.11, 6MW r =− 0.17, P = 0.17, gait
speed r =− 0.13, P = 0.30). The analysis between absolute
sarcopenia and both strength and power revealed generally
higher regression coeﬃcients for the low (strength r = 0.23,
power r = 0.46, P<0.001) and medium fat tertiles (strength
r = 0.47, power r = 0.57, P<0.001) and lower regression
coeﬃcients for the higher fat tertile (strength r = 0.16,
P = 0.20 power r = 0.24, P<0.05).
4. Discussion
We completed a sarcopenia proﬁle of 202 nonobese
community-dwelling older adults. This allowed us to look
at sarcopenia in both absolute (ASM/ht2)a n dr e l a t i v e
(ASM/kg) terms. Consistent with previous literature [3, 13],
the prevalence of sarcopenia increases when reported in
relative versus absolute terms. The novel ﬁndings from this
study are that relative sarcopenia was moderately related to
a 9-item composite measure of actual physical performance,
to the distance walked in six minutes and also to preferred
gait speed in males and females. While we identiﬁed weaker,
butsigniﬁcantrelationshipsbetweenabsolutesarcopeniaand
6MW and between absolute sarcopenia and gait speed in
females, no relationship existed between functional perfor-
mance and absolute sarcopenia in the males. Other authors
have suggested that relative sarcopenia seems to better
capture the relationship between lean mass and physical
performance [3, 14–16]; however, our data goes further,
suggesting that total body fat modulates the relationship
betweensarcopeniaandfunctionalperformanceinnonobese
older adults. There was a clear trend toward diminished
regression coeﬃcients across each incrementally higher fat
grouping for the physical performance variables. These
ﬁndings contribute to the rapidly growing trend considering
sarcopenia relative to total body mass, and not simply total
lean mass.4 Current Gerontology and Geriatrics Research
Table 2: Bivariate Correlation Results. Absolute (ASM/Ht2) and relative (ASM/kg) sarcopenia and modiﬁed physical performance test
(mPPT), six-minute walk (6MW), gait speed, normalized knee extension strength (N/BMI), and normalized leg extensor power (W/BMI).
Absolute sarcopenia Relative sarcopenia
Males P Females P Males P Females P
mPPT 0.03 0.77 0.07 0.36 0.43 <0.001 0.39 <0.001
6MW 0.03 0.73 0.16 0.02 0.48 <0.001 0.51 <0.001
Gait speed 0.04 0.67 0.14 0.05 0.31 0.002 0.41 <0.001
Knee ext strength −0.04 0.69 0.27 <0.001 0.47 <0.001 0.67 <0.001
Leg ext power 0.16 0.10 0.41 <0.001 0.48 <0.001 0.66 <0.001
−0.2
−0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
Low fat Medium
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High fat
mPPT
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Figure 1: Standardized regression coeﬃcients between absolute
sarcopenia scores (independent variable) and mPPT score, 6-
minute walk distance, gait speed, knee extensor strength, and lower
extremity power (dependent variables) across equal low (34 males,
33females),medium(34males,33females),andhigh-fat(34males,
34 females) tertiles.
By stratifying the individuals in this study into tertiles
of total body fat, our data clariﬁes that as total body fat
increases, there is a diminished relationship between the
independent variable of absolute sarcopenia with actual
physical performance (PPT, 6MW, and gait speed). More-
over, it appears that in older adults with higher body fat,
absolute sarcopenia does not have as strong a relationship
to muscle function (strength and power) as it does in older
adults with medium-to-lower amounts of total body fat,
suggesting that there may be a total body fat threshold at or
over which may interfere with the relationship between lean
tissue and functional performance.
The ﬁndings from this study introduce a plausible
explanation why other studies have failed to demonstrate
a relationship between sarcopenia and function, and why
they have concluded that lean tissue mass is not linked to
physical function in older adults. Our results suggest that
in nonobese older adults who have lower total body fat
relative to nonobese older adults who have higher total body
fat, lean tissue mass may in fact be an important variable
that inﬂuences physical function. Excess fat deposition may
also contribute to a loss of lean tissue via inﬂammatory
mechanisms, as cytokines have been shown to have direct
catabolic eﬀects on muscle [17]. Clinical support of this
assertion is found in a recent paper by Koster et al. [18], who
reportedinnonobeseolderadultsthatalthoughgreaterbody
fat mass was related to greater leg lean mass at baseline, body
fat mass was also related to a signiﬁcantly greater loss of leg
lean mass over a seven-year follow-up.
An alternate way of interpreting our data is that even
in a group of older adults who are not considered obese by
BMI measurement, total body fat impacts physical function.
This may be explained, in part, by the suggestion that
BMI is not the best indicator of total body fat content in
the older adult population and may remain stable in the
presence of signiﬁcant body composition alterations [19].
For example, a loss of muscle mass may go unnoticed in
older adults who maintain or even gain fat mass. Middle-
aged adults with normal BMI values but excess total body
fat have recently been identiﬁed as normal weight obese
(NWO). Just as individuals falling into this NWO category
have been shown to be at higher cardiovascular disease
risk [20], it may be that a similar category exists in older
adults with parallel relationships with physical function. The
stronger relationships observed between relative sarcopenia
and physical function in this study may be due, in part,
to the extra load carried by the participants in the higher
fat tertiles. The physical performance consequence of excess
fat deposition is in part substantiated by recently reported
relationships between ectopic fat deposits in locomotor
skeletal muscle (intramuscular adipose tissue) and muscle
strength and quality [21, 22], mobility [23, 24], physical
activity [25], and disability [26] in older adults. The direct
inﬂuenceofintramuscularadiposetissueonmusclefunction
in this population should be further investigated. This may
be especially important considering the recent trends of
increasedsedentarytimeanddecreasedphysicalactivitywith
advancing age and the impact of these trends on adipose
depositions, loss of muscle mass, and decreased physical
function.
The results of this study should be considered in light of
severallimitations.Theolderadultsinthisinvestigationwere
for the most part high functioning individuals who fell into
a relatively narrow BMI range with a mean BMI less than
27.0kg/m2. In particular, it should be noted that individuals
with the lowest levels of mobility function, that is, unable to
independently ambulate, were not included in this sample.
These results, therefore, cannot be generalized to all older
adults. Ultimately, the clinical utility of these relationships
will become apparent by determining whether interventionsCurrent Gerontology and Geriatrics Research 5
aimed at reducing fat deposition and increasing lean body
mass in nonobese older adults result in improved physical
function. Though this study was not designed to answer this
question, future investigations should determine the impact
of interventions on changing both body composition and
physicalfunctioninthispopulation.Anadditionallimitation
is that we were unable to deﬁne a relative sarcopenia cut-
oﬀ for males and used a best estimate based on the available
literature. However, we do not think this limitation detracts
fromourﬁndings,asthiswasnottheprimarypurposeofour
investigation.
In nonobese older adults, total body fat modulates the
relationship between sarcopenia and physical function. In
nonobese older adults who have low amounts of total body
fat, lean tissue appears to take on more clinical importance.
While decreasing overall body fat even in those who are
not traditionally considered obese appears warranted, frail
individuals who have low BMI may speciﬁcally beneﬁt from
interventions aimed at increasing lean tissue mass. This
point has recently been overshadowed by the most recent
data characterizing lean mass as less important to physical
function in older adults.
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